1 year return (CAGR)
19.17%
Ascendis Pharma AS Exchange (NASDAQ, USD)
ASND
237.59
+0.87 (+0.37%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
31.96%
5 year return (CAGR)
8.58%
10 year return (CAGR)
28.27%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
15.58B
Price/Sales
14.78
Ent value
15.62B
Price/Book
10.85
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
20.62
PEG
-
Forward P/E
29.12
EPS growth
-15.27%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 238.66 |
| Daily high | 241.50 |
| Daily low | 237.00 |
| Daily Volume | 810K |
| All-time high | 277.18 |
| 1y analyst estimate | 314.82 |
| Beta | 0.48 |
| EPS (TTM) | 11.06 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ASND | S&P500 | |
| Current price drop from All-time high | -14.28% | -0.56% |
| Highest price drop | -61.72% | -56.47% |
| Date of highest drop | 28 Apr 2023 | 9 Mar 2009 |
| Avg drop from high | -18.41% | -10.68% |
| Avg time to new high | 26 days | 12 days |
| Max time to new high | 1163 days | 1805 days |
News
